检测UDP-葡萄糖P2Y14R:一种新的炎症点
Ji-Zhou Zhang1, Nan-Rui Shi1, Jia-Si Wu1
1International Joint Research Centre on Purinergic Signalling, School of Acupuncture and Tuina/Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.
Neuropharmacology
|July 9, 2023
概括
尿液5'-二糖 (UDP-G) 通过P2Y14受体发出信号,作为与损伤相关的分子模式来驱动炎症. 针对这种途径为新型抗炎疗法提供了潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 细胞外UDP糖,特别是UDP-G,在细胞损伤和细胞亡过程中充当损伤相关分子模式 (DAMPs).
- UDP-G是一种强大的内源性激动剂,对P2Y14受体 (P2Y14R) 具有很高的亲和力.
研究的目的:
- 审查P2Y14Rs与UDP-G结合的表达和功能.
- 总结UDP-G/P2Y14R信号传导在调节炎症反应中的作用.
- 讨论炎症相关疾病中的P2Y14R激活机制和治疗潜力.
主要方法:
- 文献审查侧重于UDP-G,P2Y14R和炎症通路.
- 对信号级联的分析,包括cAMP,NLRP3炎症酶,MAPK和STAT1.
- 在炎症条件下检查P2Y14R激动剂/对抗剂.
主要成果:
- 对P2Y14R的UDP-G结合通过特定的信号通路调节炎症.
- UDP-G/P2Y14R信号调节免疫反应,包括中性粒细胞的招募和化学激素的释放.
- 新出现的证据将UDP-G/P2Y14R通路与各种与炎症相关的疾病联系起来.
结论:
- P2Y14R在免疫系统和炎症过程中起着重要作用.
- UDP-G/P2Y14R信号传递是抗炎策略的一个有前途的治疗点.
- P2Y14Rs的新型激素和对抗剂在治疗炎症病症方面显示出潜在的应用.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
566
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
566
01:24Glucagon-like Receptor Agonists
365
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
365
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K